Cargando…
Automatic Classification of Cancer Pathology Reports: A Systematic Review
Pathology reports primarily consist of unstructured free text and thus the clinical information contained in the reports is not trivial to access or query. Multiple natural language processing (NLP) techniques have been proposed to automate the coding of pathology reports via text classification. In...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860734/ https://www.ncbi.nlm.nih.gov/pubmed/35242443 http://dx.doi.org/10.1016/j.jpi.2022.100003 |
Sumario: | Pathology reports primarily consist of unstructured free text and thus the clinical information contained in the reports is not trivial to access or query. Multiple natural language processing (NLP) techniques have been proposed to automate the coding of pathology reports via text classification. In this systematic review, we follow the guidelines proposed by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA; Page et al., 2020: BMJ.) to identify the NLP systems for classifying pathology reports published between the years of 2010 and 2021. Based on our search criteria, a total of 3445 records were retrieved, and 25 articles met the final review criteria. We benchmarked the systems based on methodology, complexity of the prediction task and core types of NLP models: i) Rule-based and Intelligent systems, ii) statistical machine learning, and iii) deep learning. While certain tasks are well addressed by these models, many others have limitations and remain as open challenges, such as, extraction of many cancer characteristics (size, shape, type of cancer, others) from pathology reports. We investigated the final set of papers (25) and addressed their potential as well as their limitations. We hope that this systematic review helps researchers prioritize the development of innovated approaches to tackle the current limitations and help the advancement of cancer research. |
---|